Literature DB >> 22345304

Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007.

Youxin Wang1, Wei Wang2.   

Abstract

Increasing incidence of thyroid cancer has been observed in some countries such as the United States, United Kingdom, France, and so on. Joinpoint regression was used to analyze the incidence of thyroid cancer in Shanghai, China, from 1983 to 2007. The results showed that there were 2 distinct slopes: in men, representing a significant annual percentage change (APC) of 2.6% from 1983 to 2000 (P < .001) followed by a sharp APC of 14.4% (P < .001), and in women, representing a significant APC of 4.9% from 1983 to 2003 (P < .001) followed by a sharp APC of 19.9% (P = .001). The sharp increase in thyroid cancer occurred 5 and 8 years after the iodine supplementation by salt, for men and women, respectively, suggesting that either the developed screening techniques or iodine supplementation might have contributed to the rapid increase in the incidence of thyroid cancer. The burden of thyroid cancer cases is expected to be substantial, based on predictions through 2020.
© 2012 APJPH.

Entities:  

Keywords:  China; Joinpoint regression; future burdens; incidence of thyroid cancer

Mesh:

Year:  2012        PMID: 22345304     DOI: 10.1177/1010539512436874

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  51 in total

1.  Rising incidence of thyroid cancer in Serbia.

Authors:  N Slijepcevic; V Zivaljevic; I Paunovic; A Diklic; Perisic Zivkovic; D Miljus; A Grgurevic; S Sipetic
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

2.  Candidate agents for papillary thyroid cancer identified by gene expression analysis.

Authors:  Wei Zhu; Chen Li; Zhilong Ai
Journal:  Pathol Oncol Res       Date:  2013-03-22       Impact factor: 3.201

3.  Abnormality of pl6/p38MAPK/p53/Wipl pathway in papillary thyroid cancer.

Authors:  Dehua Yang; Hao Zhang; Xinhua Hu; Shijie Xin; Zhiquan Duan
Journal:  Gland Surg       Date:  2012-05

4.  The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Authors:  Yun Zhang; Jiaqi Dai; Tingting Wu; Nailin Yang; Zhiqiang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-12       Impact factor: 4.553

Review 5.  The role of surgery in the current management of differentiated thyroid cancer.

Authors:  Giovanni Conzo; Nicola Avenia; Giuseppe Bellastella; Giancarlo Candela; Annamaria de Bellis; Katherine Esposito; Daniela Pasquali; Andrea Polistena; Luigi Santini; Antonio Agostino Sinisi
Journal:  Endocrine       Date:  2014-04-10       Impact factor: 3.633

Review 6.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

7.  Contrast-enhanced ultrasound and real-time elastography in the differential diagnosis of malignant and benign thyroid nodules.

Authors:  Xin Sui; Huai-Jun Liu; Hong-Li Jia; Qin-Mao Fang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

Review 8.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

9.  BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients.

Authors:  F J Huang; W Y Fang; L Ye; X F Zhang; L Y Shen; R L Han; Q Wei; X C Fei; X Chen; W Q Wang; S Wang; G Ning
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

10.  MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.

Authors:  Yanhua Yang; Shujun Xia; Lu Zhang; Wenhan Wang; Lin Chen; Weiwei Zhan
Journal:  Cancer Biol Ther       Date:  2020-03-10       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.